KLK8 and depressive symptom measurement: In this study, we aimed at testing if epigenetic variation in the KLK8 promoter region, recently implicated with depression symptomatology through EWAS [17], is associated with depression severity scores and depression case–control status first in an independent clinical PRISME cohort.